Literature DB >> 7897446

Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and research. Network of European CNS Transplantation and Restoration (NECTAR).

G J Boer1.   

Abstract

Recently a Network of European CNS Transplantation And Restoration (NECTAR) has been founded, aimed at a concerted effort to develop efficient, reliable, safe and ethically acceptable transplantation therapies for neurodegenerative diseases, in particular Parkinson's and Huntington's disease. Owing to the use of human fetal brain tissue in such studies, usually obtained from elective abortions, ethical concerns have been focused on the relationship between abortion and transplantation activities. There is no uniform code on the retrieval and use of human embryonal or fetal material for experimental and clinical research or application in Europe. NECTAR has therefore formulated self-restraining ethical guidelines for its European member groups. These guidelines consist of a series of restrictions intended to prevent the use of grafts from encouraging induced abortions and to maintain high standards of respect for life and human dignity. In order to support applications for human embryonal or fetal neurotransplantation studies of NECTAR member groups to local or national medico-ethical committees, and to stimulate the goal of obtaining European legislation on this issue, the guidelines are here presented. They are followed by extensive explanatory notes. Only in this public manner can the lines of thought behind these NECTAR guidelines be addressed critically by those working in the fields of biomedical ethics and legislation as well by politicians and the general public.

Entities:  

Keywords:  Genetics and Reproduction; Health Care and Public Health; Network of European CNS Transplantation and Restoration (NECTAR)

Mesh:

Year:  1994        PMID: 7897446     DOI: 10.1007/bf00920568

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

1.  University policy on experimental use of aborted fetal tissue: case study.

Authors:  James Tunstead Burtchaell
Journal:  IRB       Date:  1988 Jul-Aug

2.  Ethical issues in brain-cell transplantation.

Authors:  B J Hoffer; L Olson
Journal:  Trends Neurosci       Date:  1991-08       Impact factor: 13.837

3.  Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants.

Authors:  O Lindvall; H Widner; S Rehncrona; P Brundin; P Odin; B Gustavii; R Frackowiak; K L Leenders; G Sawle; J C Rothwell
Journal:  Ann Neurol       Date:  1992-02       Impact factor: 10.422

4.  The use of embryo or fetus in transplantation: what there is to lose.

Authors:  K Nolan
Journal:  Transplant Proc       Date:  1990-06       Impact factor: 1.066

5.  Council of Europe, Parliamentary Assembly Recommendation 1046 (1986) (1) on the use of human embryos and fetuses for diagnostic, therapeutic, scientific, industrial and commercial purposes.

Authors: 
Journal:  Hum Reprod       Date:  1987-01       Impact factor: 6.918

Review 6.  Legal regulation of fetal tissue transplantation.

Authors:  P King; J Areen
Journal:  Clin Res       Date:  1988-04

7.  Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease.

Authors:  P Brundin; O G Nilsson; R E Strecker; O Lindvall; B Astedt; A Björklund
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

8.  Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease.

Authors:  B T Henderson; C G Clough; R C Hughes; E R Hitchcock; B G Kenny
Journal:  Arch Neurol       Date:  1991-08

9.  Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Authors:  H Widner; J Tetrud; S Rehncrona; B Snow; P Brundin; B Gustavii; A Björklund; O Lindvall; J W Langston
Journal:  N Engl J Med       Date:  1992-11-26       Impact factor: 91.245

10.  Women's self-reported responses to abortion.

Authors:  G M Burnell; M A Norfleet
Journal:  J Psychol       Date:  1987-01
View more
  16 in total

Review 1.  Neural transplantation in patients with Huntington's disease.

Authors:  Anne E Rosser; Stephen B Dunnett
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Cell therapy in Huntington's disease.

Authors:  Stephen B Dunnett; Anne E Rosser
Journal:  NeuroRx       Date:  2004-10

Review 3.  Regenerative therapy for neuronal diseases with transplantation of somatic stem cells.

Authors:  Hiroshi Kanno
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 4.  Do brain tissue transplants alter personal identity? Inadequacies of some "standard" arguments.

Authors:  G Northoff
Journal:  J Med Ethics       Date:  1996-06       Impact factor: 2.903

Review 5.  Fetal stem cell transplantation: Past, present, and future.

Authors:  Tetsuya Ishii; Koji Eto
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

Review 6.  Ethical issues in neurografting of human embryonic cells.

Authors:  G J Boer
Journal:  Theor Med Bioeth       Date:  1999-09

7.  Sham neurosurgery in patients with Parkinson's disease: is it morally acceptable?

Authors:  W Dekkers; G Boer
Journal:  J Med Ethics       Date:  2001-06       Impact factor: 2.903

8.  Pre-embryo research.

Authors:  G R Dunstan
Journal:  J Assist Reprod Genet       Date:  1995-09       Impact factor: 3.412

9.  Ethical guidance on human embryonic and fetal tissue transplantation: a European overview.

Authors:  Wert G de; R L Berghmans; G J Boer; S Andersen; B Brambati; A S Carvalho; K Dierickx; S Elliston; P Nunez; W Osswald; M Vicari
Journal:  Med Health Care Philos       Date:  2002

10.  Characterization of Three-Dimensional Retinal Tissue Derived from Human Embryonic Stem Cells in Adherent Monolayer Cultures.

Authors:  Ratnesh K Singh; Ramya K Mallela; Pamela K Cornuet; Aaron N Reifler; Andrew P Chervenak; Michael D West; Kwoon Y Wong; Igor O Nasonkin
Journal:  Stem Cells Dev       Date:  2015-09-10       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.